Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies-Reference-Cited by-同舟云学术

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies

Published:2017-12-28 Issue:3 Volume:40 Page:584-589
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Rodriguez Cristina P.¹^ORCID,Martins Renato G.¹,Baik Christina¹,Chow Laura Q.¹,Santana-Davila Rafael¹,Goulart Bernardo H.²,Lee Sylvia¹,Eaton Keith D.¹

Affiliation:

1. Division of Medical Oncology, Department of Medicine; University of Washington; Seattle WA

2. Fred Hutchinson Cancer Research Center; Seattle WA

Funder

Eisai

Publisher

Wiley

Subject

Otorhinolaryngology

Reference27 articles.

1. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch Head and Neck Oncology Cooperative Group;Terhaard;Head Neck.,2004

2. Postoperative radiotherapy for malignant tumors of the parotid gland;Garden;Int J Radiat Oncol Biol Phys.,1997

3. Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group;Gilbert;Head Neck.,2006

4. A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials Group;Laurie;Cancer.,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2–expressing salivary gland carcinoma: a pooled analysis of two phase I studies;Japanese Journal of Clinical Oncology;2024-01-16

2. NISCAHN: a phase II trial of nivolumab in patients with salivary gland carcinoma (Unicancer ORL-08);BMJ Oncology;2023-10

3. The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?;International Journal of Molecular Sciences;2022-11-28

4. Approaches to the Management of Metastatic Adenoid Cystic Carcinoma;Cancers;2022-11-20

5. Liposomal eribulin for advanced adenoid cystic carcinoma, gastric cancer, esophageal cancer, and small cell lung cancer;Cancer Medicine;2022-07-21